Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1854 News Items found Education MSK’s Summer Cancer Research Program Gives Opportunity to Diverse College Students Thursday, August 29, 2024 A summer program offers college students from underrepresented communities a chance to get valuable research experience. Facing Cancer Alone Doesn’t Have to Feel Lonely Wednesday, August 28, 2024 In their 60-year love story, Bobbie and Barbara went through multiple cancers together. Now MSK social worker Sabrina Feldman is helping Bobbie to find new meaning, connection, and comfort, as he continues treatment without Barbara by his side. In the Clinic 6 Things Women Should Know About Ovarian Cancer Thursday, August 22, 2024 Dennis Chi lists the most important things to remember about ovarian cancer. Feature Robotic Neurosurgery at MSK Speeds Recovery From Some Spinal Tumors Wednesday, August 21, 2024 MSK surgeons have regularly used robotic surgery since 2007 to remove certain tumors in the chest and abdominal cavity. Now they are using robotic surgery to remove noncancerous tumors of the spine. Caregiving New Program to Get a Better Night’s Sleep in the Hospital Thursday, August 15, 2024 Read about an MSK pilot study that could help patients get better sleep in the hospital overnight. MSK Research Highlights, August 13, 2024 Tuesday, August 13, 2024 New MSK research found patients with non-small cell lung cancer brain metastases may benefit from up-front stereotactic radiosurgery; identified a connection between antibiotic use and autoimmune diseases; and uncovered a previously unknown structural role for messenger RNAs in the cytoplasm of cells. FDA Approves Drug for Low-Grade Glioma With IDH Gene Mutation Wednesday, August 7, 2024 A new drug could be an effective treatment for some people with low-grade glioma. In the Clinic FDA Approves First Engineered Cell Therapy for Treating Rare Sarcoma Friday, August 2, 2024 The FDA has approved an engineered cell therapy called afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for treating advanced synovial sarcoma. The clinical trials resulting in the drug’s approval were led by Dr. Sandra D’Angelo of MSK. MSK Researchers Discover Source of Deadly Fungal Infections in Bone Marrow Transplant Patients, New Study Finds Friday, August 2, 2024 A team of researchers led by Memorial Sloan Kettering Cancer Center (MSK) and collaborators at Emory University are shedding new light on deadly fungal infections that develop in bone marrow transplant patients. Article FDA Approves CAR T Cell Treatment for Resistant Mantle Cell Lymphoma Wednesday, July 31, 2024 Learn how MSK researchers led the way in the approval of a new mantle cell lymphoma CAR T cell treatment. Pagination First page « First Previous page ‹ Previous … Page 24 Page 25 Page 26 Page 27 Current page 28 Page 29 Page 30 Page 31 Page 32 … Next page Next › Last page Last » Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment